Article Details

Alumis to Participate in the 2024 Leerink Partners Global Biopharma Conference | BioSpace

Retrieved on: 2024-03-11 16:46:14

Tags for this article:

Click the tags to see associated articles and topics

Alumis to Participate in the 2024 Leerink Partners Global Biopharma Conference | BioSpace. View article details on HISWAI: https://www.biospace.com/article/releases/alumis-to-participate-in-the-2024-leerink-partners-global-biopharma-conference/

Summary

The article highlights Alumis Inc., a biopharmaceutical company, focusing on developing oral therapies targeting tyrosine kinase 2 for immune-mediated diseases like uveitis, within the broader field of immunology.

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up